T43.213D Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter

Name of the Condition

• Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter

Summary

This condition involves poisoning by selective serotonin and norepinephrine reuptake inhibitors (SNRIs) resulting from an assault, with the encounter classified as subsequent. SNRIs are a class of antidepressant medications. The diagnosis is based on clinical presentation, medication history, and confirmation of the assault as the cause of exposure, with the "subsequent encounter" designation indicating follow-up care after the initial event.

Causes

Poisoning occurs when an individual is intentionally exposed to an excessive amount of SNRIs as part of an assault. This may involve forced ingestion or administration of the medication by another party. The "subsequent encounter" modifier applies to care provided during the recovery or follow-up phase after the initial poisoning event.

Risk Factors

• Victim of interpersonal violence or abuse.
• Situations where access to medications is uncontrolled.
• Circumstances involving coercion or forced administration of substances.
• Lack of awareness or ability to refuse unwanted medication exposure.

Symptoms

• Nausea, vomiting, or abdominal pain.
• Dizziness, drowsiness, or confusion.
• Rapid heart rate or changes in blood pressure.
• Tremors, seizures, or muscle rigidity.
• Excessive sweating or fever.
• Respiratory depression or failure (in severe cases).

Diagnosis

Diagnosis is based on a thorough patient history, including details of the assault and medication exposure, along with clinical assessment of symptoms. Laboratory tests may be used to confirm the presence of SNRIs or rule out other causes. The "subsequent encounter" modifier is applied when the patient is receiving follow-up care for the poisoning.

Treatment Options

Treatment focuses on managing symptoms and supporting recovery. This may include monitoring vital signs, administering activated charcoal (if appropriate), and providing supportive care such as intravenous fluids or medications to address specific symptoms like seizures or arrhythmias. Follow-up care may involve addressing psychological impacts of the assault.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and the timeliness of treatment. Most patients recover with appropriate care, but severe cases may require prolonged monitoring. Follow-up care often includes assessing for lingering physical or psychological effects and coordinating with mental health or social services as needed.

Complications

• Persistent neurological symptoms (e.g., confusion, tremors).
• Cardiovascular issues (e.g., irregular heart rate, blood pressure fluctuations).
• Psychological trauma related to the assault.
• Respiratory problems if severe poisoning occurred.

Lifestyle & Prevention

• Ensure medications are stored securely to prevent unauthorized access.
• Seek support from healthcare providers or advocacy groups if experiencing interpersonal violence.
• Follow prescribed medication regimens carefully to avoid accidental overdose.
• Report any suspected abuse or coercion to appropriate authorities.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., severe dizziness, seizures, difficulty breathing) occur. Follow up with a healthcare provider for ongoing care if experiencing persistent symptoms or psychological distress after the event.

Tips for Medical Coders

Use this code for subsequent encounters related to poisoning by SNRIs due to assault. Document the nature of the exposure (assault), the type of medication (SNRI), and the encounter type (subsequent) to support coding. Ensure clinical documentation aligns with the "subsequent encounter" definition, indicating follow-up care rather than the initial event.